Allergy, acute medicine and critical care · FICTIONAL CASE

Anaphylaxis after two adrenaline doses: recognise refractory shock

Recognise refractory anaphylaxis, continue first-line priorities and escalate safely without inappropriate intravenous adrenaline boluses.

Reassessment, escalation and treatment safety15 minutes0/3 decisions explored
PAUSE BEFORE USING

This is educational content, not a clinical protocol. Verify current guidance, use local pathways and seek appropriate senior or specialist help.

THE CASE

A fictional 38-year-old develops wheeze, widespread urticaria and hypotension minutes after an intravenous antibiotic. Symptoms persist after two correctly administered intramuscular adrenaline doses.

01 · INITIAL PRESENTATION

Listen for the assumption.

SHO

Two doses have been given, so I was preparing an intravenous adrenaline bolus.

Registrar

Before changing route, confirm positioning, oxygenation, monitoring, fluid resuscitation and whether the intramuscular doses were correctly timed and delivered.

SHO

Persistent airway, breathing or circulation compromise after two appropriate doses is refractory anaphylaxis and needs immediate expert critical-care support.

WHERE IS THE CONSULTANT?

Choose an answer below and reveal the reasoning to see consultant feedback at every checkpoint. The full consultant-led synthesis follows after all three decisions.

Go to the first decision ↓
EVOLVING INFORMATION

The picture develops.

  1. Persistent hypotension and wheeze
  2. Two appropriate intramuscular doses documented
  3. Continuous monitoring and large-bore access established
02 · DECISION CHECKPOINTS

Commit before you reveal.

After you select an option, reveal the model reasoning and the consultant’s feedback.

DECISION 1What is the safest immediate framing?
DECISION 2Which adrenaline approach is unsafe for an inexperienced clinician?
DECISION 3Should laboratory testing delay treatment?
03 · CONSULTANT-LED SYNTHESIS

Hear the senior team refine the plan.

The registrar tests the plan, the consultant synthesises the key principle, and the SHO confirms the safer next steps.

Registrar

Continue the anaphylaxis algorithm, reassess after every intervention and prepare for advanced airway and vasopressor support.

Consultant

Correct. An adrenaline infusion belongs in a monitored environment with clinicians familiar with its use; avoid improvised intravenous boluses.

SHO

I will document trigger, timing, dose, route, physiological response and the post-reaction follow-up plan.

CLINORA DECISION TRACE
01 · CUEOngoing ABC compromise after two appropriate IM adrenaline doses
02 · INTERPRETRefractory anaphylaxis
03 · ACTContinue resuscitation and activate expert critical-care management
SAFETY CHECK

What must remain explicit.

  • Follow the current Resuscitation Council UK algorithm and local emergency policy.
  • Do not allow tests to delay treatment.
  • Use intravenous adrenaline only with appropriate expertise and monitoring.
COMMON ERRORS

Where reasoning fails.

  • Treating skin signs rather than ABC compromise
  • Unsupervised intravenous adrenaline bolus
  • Failing to reassess dose timing and response
STRUCTURED HANDOVER
Suspected trigger [detail], onset [time], ABC features [trend], adrenaline [dose/route/times], fluids and adjuncts [response], refractory criteria [details] and critical-care plan [status].
REFLECTIVE PAUSE

Where is the refractory anaphylaxis algorithm located in your clinical area?